comparemela.com

Latest Breaking News On - John mascarenhas - Page 11 : comparemela.com

CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia

/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the.

New yorkUnited statesAdamr craigJohn mascarenhasIcahn school of medicine at mount sinaiTisch cancer instituteSecurities exchangeDrug administrationBiopharma corpAssociate professorMedical oncologyIcahn schoolMount sinaiChief executive officerJanus associated kinaseAdverse cardiac events

FDA Approves First Drug for Myelofibrosis With Thrombocytopenia

Pacritinib is indicated specifically for patients with myelofibrosis and very low platelet counts, which develop in about one third of patients.

New yorkUnited statesPacritinib vonjoJohn mascarenhasTisch cancer instituteDrug administrationIcahn school of medicineIcahn schoolMount sinaiMedscape medicalPlatelet countLatelet count pltHrombocyte countPolycythemia veraRimary polycythemiaAlignant neoplasia

FDA OKs First Drug for Cytopenic Myelofibrosis

Approval of pacritinib was based on results from the phase III PERSIST-2 trial

New yorkUnited statesJohn mascarenhasMike bassettIcahn school of medicine at mount sinaiIcahn schoolMount sinaiNew york city

FDA Approves Pacritinib for Treatment of Myelofibrosis

Pacritinib fills a treatment gap for patients with myelofibrosis and a low platelet count

New yorkUnited statesJohn mascarenhasDrug administrationResearch foundationBlood cancersMyeloid disordersMount sinai icahn schoolNew york city

Mount Sinai Researchers Present Encouraging Clinical Trial Results on Novel Therapy for Bone Marrow Cancer

New York, NY (PRWEB) December 11, 2021 Mount Sinai physician-scientists have found that a novel therapy for the bone marrow cancer myelofibrosis is safe

New yorkUnited statesLong islandJohn mascarenhasLillian varricchioRonald hoffmanAnna rita migliaccioHealth systemTisch cancer instituteNational institutes of healthNational cancer centerTisch cancer institute at mount sinaiAmerican society of hematologyMount sinai health systemIcahn school of medicineBlood cancer

vimarsana © 2020. All Rights Reserved.